Bill
S 222
Mass. S.222 creates a licensing regime for hemp‑derived infused beverages, mandating independent testing, labeling, fees, and enforcement to protect consumers.
Status & procedural history (as provided)
- Introduced in the Massachusetts Senate by Sen. William J. Driscoll, Jr. (filed Jan. 17–23, 2025).
- Referred to legislative committees (including Consumer Protection & Professional Licensure and Codes). The provided docket also lists later procedural entries (hearings, committee reports, calendar placement) and additional actions dated through Nov. 2025. Note: some metadata in the record (sponsor list and certain committee actions) appears to mix federal Senate entries; consult the official Massachusetts Legislature site for the authoritative, current status and final text.
Purpose / intent
- Create a regulatory framework for “infused beverages” — non‑alcoholic beverages that contain or are marketed as containing intoxicating or non‑intoxicating cannabinoids derived from hemp — by treating them in a manner similar to alcoholic beverage manufacturing and imposing licensing, testing, labeling, and enforcement requirements to protect consumers.
Key definitions (selected)
- Infused beverage / infused beverage product: any non‑alcoholic beverage intended for human consumption that contains or is marketed as containing an intoxicating cannabinoid; such products are explicitly not classified as “food” in this bill.
- Intoxicating cannabinoid: cannabinoids with intoxicating properties (examples listed include delta‑6, delta‑8, delta‑9, delta‑10 THC and delta‑9‑THC acid A).
- Non‑intoxicating cannabinoid: cannabinoids without intoxicating properties (examples include CBD, CBG, CBN, and related acids).
- Artificially‑derived cannabinoid: synthetically produced cannabinoids (with specified exceptions).
- Transportable hemp concentrate: concentrated hemp product meeting specified THC thresholds intended for processing into infused beverages.
- Independent testing laboratory: must be ISO/IEC 17025 accredited and independent from producers/processors/retailers.
Major provisions & requirements
- Licensing/endorsements: Manufacturing infused beverages for sale in the Commonwealth requires an “infused beverage manufacturer endorsement” or a certificate of compliance issued by “the commission.” Endorsements are annual and renewable.
- Eligibility: The commission may only issue an endorsement if the applicant holds an unencumbered license to manufacture alcoholic beverages (chapter 138 §19), marijuana‑infused products under chapter 94G, or hemp products under chapter 128.
- Fees & timing: Application processing fee is $5,000; the commission must approve/deny applications within 30 days.
- Sales restrictions: Holders of endorsements may only sell infused beverage products to other entities that hold the appropriate manufacturing or wholesale/sales endorsement or certificate.
- Testing & analysis: Products must be tested by independent, accredited labs; certificates of analysis are required (text indicates testing and lab accreditation standards).
- Enforcement & penalties: The commission may fine up to $10,000 for operating, advertising, or establishing an infused beverage manufacturing operation without the required endorsement; each day of violation is a separate offense. The commission may suspend, revoke, or refuse renewal for cause and is authorized to conduct surveys/investigations.
Who is affected
- New and existing beverage manufacturers, cannabis/hemp product manufacturers, wholesalers and retailers who wish to produce or sell hemp‑derived cannabinoid beverages.
- Independent testing laboratories (accreditation and independence requirements).
- Regulators (the “commission” and related state agencies) — expanded enforcement and licensing duties.
- Consumers and public‑health stakeholders (changes to product availability, labeling, and safety oversight).
Potential impacts and considerations
- Restricts manufacturing and wholesale distribution to entities holding specific state manufacturing licenses, which may limit entry by some smaller producers or non‑licensed beverage companies.
- Aligns hemp‑derived cannabinoid beverages more closely with alcohol and cannabis product regulatory schemes, potentially improving product testing, labeling, and consumer protections.
- Imposes significant compliance costs (application fee, lab testing, possible infrastructure to meet licensing standards) and risk of substantial per‑day fines for noncompliance.
- The bill text included here is truncated after Section 80; subsequent sections (e.g., wholesale/retail sale rules, labeling, packaging, additional penalties or exemptions) are not fully shown and may contain further important requirements.
Recommendation
- Review the final, complete bill text and current status on the official Massachusetts legislative website or contact the sponsoring office for clarifications before making regulatory or business decisions.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
